Antares Pharma (ATRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2021 | 12-2020 | 12-2019 | 12-2018 | 12-2017 | |
| Sales | 183,982 | 149,599 | 123,864 | 63,554 | 54,515 |
| Cost of Goods | 68,281 | 63,100 | 50,475 | 31,065 | 27,466 |
| Gross Profit | 115,701 | 86,499 | 73,389 | 32,489 | 27,049 |
| Operating Expenses | 50,049 | 72,980 | 72,872 | 36,655 | 43,106 |
| Operating Income | 65,933 | 13,619 | 992 | -4,101 | -15,591 |
| Interest Expense | 3,611 | 3,787 | 3,549 | 2,675 | 1,423 |
| Other Income | -51 | 89 | 530 | 261 | 271 |
| Pre-tax Income | 62,271 | 9,921 | -2,027 | -6,515 | -16,743 |
| Income Tax | 15,982 | -46,280 | N/A | N/A | N/A |
| Net Income Continuous | 46,289 | 56,201 | -2,027 | -6,515 | -16,743 |
| Net Income | $46,289 | $56,201 | $-2,027 | $-6,515 | $-16,743 |
| EPS Basic Total Ops | 0.27 | 0.34 | -0.01 | -0.04 | -0.11 |
| EPS Basic Continuous Ops | 0.27 | 0.34 | -0.01 | -0.04 | -0.11 |
| EPS Diluted Total Ops | 0.26 | 0.33 | -0.01 | -0.04 | -0.11 |
| EPS Diluted Continuous Ops | 0.26 | 0.33 | -0.01 | -0.04 | -0.11 |
| EPS Diluted Before Non-Recurring Items | 0.10 | 0.06 | -0.01 | -0.04 | -0.11 |
| EBITDA(a) | $69,834 | $16,246 | $3,549 | $-1,377 | $-13,487 |